[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 427
Citations 0
Invited Commentary
April 2016

Oral Fluoroquinolones, Retinal Detachments, and Claims Database Studies

Author Affiliations
  • 1Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  • 2Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  • 3Leonard Davis Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
JAMA Ophthalmol. 2016;134(4):422-423. doi:10.1001/jamaophthalmol.2016.0240

In this issue of JAMA Opthalmology, Raguideau et al1 add to the literature supporting an association between oral fluoroquinolone use and an increased risk of retinal detachment (RD). Understanding the potential adverse events associated with fluoroquinolone use is of great public health importance owing to its widespread clinical usefulness. In performing this study, the authors used 2 French national administrative medical claims databases to generate their data. Although databases similar to the ones used within this study have been commonly used in observational research across most other medical specialties for the past 25 years, their application to ophthalmic research has only become more commonplace in recent years. Because of this, it is important to remember both the inherent strengths and weaknesses that these types of databases offer before the reported association is applied to clinical decision making.

First Page Preview View Large
First page PDF preview
First page PDF preview
×